REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 198 filers reported holding REPLIGEN CORP in Q2 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,522,087 | +8.5% | 173,084 | -3.5% | 1.83% | +19.6% |
Q2 2023 | $25,375,378 | -27.6% | 179,382 | -13.8% | 1.53% | -34.9% |
Q1 2023 | $35,025,278 | +6.3% | 208,038 | +6.9% | 2.35% | -4.0% |
Q4 2022 | $32,937,737 | -6.8% | 194,541 | +3.0% | 2.44% | -11.9% |
Q3 2022 | $35,353,000 | -3.4% | 188,944 | -16.1% | 2.78% | +0.3% |
Q2 2022 | $36,580,000 | +8.1% | 225,247 | +25.2% | 2.77% | +29.5% |
Q1 2022 | $33,833,000 | -27.1% | 179,877 | +2.7% | 2.14% | -15.6% |
Q4 2021 | $46,394,000 | -14.5% | 175,179 | -6.7% | 2.53% | -12.5% |
Q3 2021 | $54,250,000 | -9.5% | 187,723 | -37.5% | 2.90% | -7.5% |
Q2 2021 | $59,964,000 | +0.3% | 300,391 | -2.3% | 3.13% | -4.8% |
Q1 2021 | $59,761,000 | -8.2% | 307,399 | -9.5% | 3.29% | -4.2% |
Q4 2020 | $65,110,000 | +20.6% | 339,771 | -7.1% | 3.43% | -0.0% |
Q3 2020 | $53,983,000 | +5.4% | 365,884 | -11.7% | 3.43% | -2.1% |
Q2 2020 | $51,194,000 | +12.7% | 414,161 | -12.0% | 3.51% | -12.3% |
Q1 2020 | $45,442,000 | -5.8% | 470,709 | -9.7% | 4.00% | +25.7% |
Q4 2019 | $48,223,000 | +44.9% | 521,331 | +20.1% | 3.18% | +33.3% |
Q3 2019 | $33,286,000 | -26.2% | 434,031 | -17.3% | 2.39% | -22.4% |
Q2 2019 | $45,085,000 | +44.0% | 524,551 | -1.0% | 3.07% | +35.7% |
Q1 2019 | $31,316,000 | -3.9% | 530,056 | -14.2% | 2.26% | -14.8% |
Q4 2018 | $32,575,000 | -6.4% | 617,661 | -1.5% | 2.66% | +15.7% |
Q3 2018 | $34,791,000 | -12.9% | 627,311 | -26.1% | 2.30% | -17.8% |
Q2 2018 | $39,936,000 | +59.6% | 848,989 | +22.8% | 2.79% | +51.2% |
Q1 2018 | $25,016,000 | -1.6% | 691,422 | -1.3% | 1.85% | -1.1% |
Q4 2017 | $25,418,000 | -9.7% | 700,612 | -4.6% | 1.87% | -11.5% |
Q3 2017 | $28,136,000 | -26.2% | 734,232 | -20.1% | 2.11% | -22.3% |
Q2 2017 | $38,099,000 | +15.5% | 919,366 | -1.9% | 2.72% | +13.5% |
Q1 2017 | $32,983,000 | +12.5% | 937,006 | -1.5% | 2.39% | +15.0% |
Q4 2016 | $29,306,000 | +26.4% | 950,881 | +23.8% | 2.08% | +25.2% |
Q3 2016 | $23,186,000 | +15.4% | 768,010 | +4.6% | 1.66% | +34.1% |
Q2 2016 | $20,085,000 | -2.3% | 734,110 | -4.2% | 1.24% | -1.7% |
Q1 2016 | $20,556,000 | +44.7% | 766,460 | +52.6% | 1.26% | +50.4% |
Q4 2015 | $14,210,000 | – | 502,285 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |